Cargando…
Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
Together with aspartate, glutamate is the major excitatory neurotransmitter in the brain. Glutamate binds and activates both ligand-gated ion channels (ionotropic glutamate receptors) and a class of G-protein coupled receptors (metabotropic glutamate receptors). Although the intracellular glutamate...
Autores principales: | Lewerenz, Jan, Maher, Pamela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679930/ https://www.ncbi.nlm.nih.gov/pubmed/26733784 http://dx.doi.org/10.3389/fnins.2015.00469 |
Ejemplares similares
-
Subsequent and simultaneous electrophysiological investigation of the retina and the visual cortex in neurodegenerative and psychiatric diseases: what are the forecasts for the medicine of tomorrow?
por: Tursini, Katelyne, et al.
Publicado: (2023) -
Editorial: Golgi Pathology in Neurodegenerative Diseases
por: Rabouille, Catherine, et al.
Publicado: (2016) -
Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia
por: Madeira, Caroline, et al.
Publicado: (2018) -
Potential application of lithium in Parkinson's and other neurodegenerative diseases
por: Lazzara, Carol A., et al.
Publicado: (2015) -
Increased Absolute Glutamate Concentrations and Glutamate-to-Creatine Ratios in Patients With Methamphetamine Use Disorders
por: Yang, Wenhan, et al.
Publicado: (2018)